Grace Board of Directors Approves Separation of GCP Applied

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Grace Board of Directors Approves Separation of GCP Applied Technologies

COLUMBIA, Md., Jan. 12, 2016 (GLOBE NEWSWIRE) -- W. R. Grace & Co. (NYSE: GRA ) today announced that its Board of Directors has approved the previously announced plan to separate Grace’s Construction Products segment and Darex Packaging Technologies business from the remaining businesses of Grace to form GCP Applied Technologies Inc. (“GCP” or “GCP Applied Technologies”). The planned separation, which is expected to be generally tax-free to Grace’s U.S. shareholders, is expected to be completed on Feb. 3, 2016.

“Today's announcement marks another important milestone towards the completion of our business separation, which will create two independent, industry-leading companies,” said Fred Festa, Grace Chairman and Chief Executive Officer. “As independent companies, we believe Grace and GCP will benefit from enhanced strategic, operating, financial, and investment flexibility and are poised to generate significant value for our shareholders. We look forward to completing the final steps in this process.”

GCP Applied Technologies will have customers in more than 110 countries, operations on six continents, and a team of 2,500 employees. Through applied knowledge and service excellence, GCP Applied Technologies will provide premier specialty construction chemicals and specialty building materials for many of the world’s most renowned structures, and packaging technologies for the best-known consumer brands.

After the separation, Grace will own and operate the Company’s existing Catalysts Technologies and Materials Technologies operating segments, excluding the Darex Packaging Technologies business. Grace expects to continue to be a global leader in process catalysts and specialty silicas, and a high margin, technologically advanced business focused on sales and earnings growth, strong cash flow, and high returns on capital.

Transaction Details

The separation will occur by means of a pro rata distribution to Grace shareholders of all of the outstanding shares of GCP Applied Technologies. The distribution remains subject to satisfaction of the conditions described in the preliminary information statement included with GCP’s Registration Statement on Form 10 initially filed on Aug. 5, 2015 with the U.S. Securities and Exchange Commission (the “SEC”).

In the distribution, Grace shareholders will receive one share of GCP Applied Technologies Inc. common stock for every one share of Grace common stock held as of the close of business on Jan. 27, 2016, the record date for the distribution. Subject to the satisfaction of the conditions to the distribution, the distribution of GCP Applied Technologies common stock is expected to occur on Feb. 3, 2016. No fractional shares of GCP Applied Technologies will be issued. Shareholders will receive cash in lieu of fractional shares. 

Trading of Grace and GCP Shares

Beginning on or about Jan. 26, 2016, it is expected that “when issued” trading will begin for shares of GCP Applied Technologies common stock on the New York Stock Exchange (“NYSE”) under the ticker symbol “GCP WI”. GCP Applied Technologies common shares are expected to begin “regular way” trading on Thursday, Feb. 4, 2016, on the NYSE under the ticker symbol “GCP”.

Also beginning on or about Jan. 26, 2016, and continuing through the distribution date, it is expected that there will be two markets in Grace common stock. Grace shares that trade in the “regular-way” market under the symbol “GRA” will trade with an entitlement to shares of GCP Applied Technologies common stock to be distributed pursuant to the distribution; shares that trade in the “ex-distribution” market under the symbol “GRA WI” will trade without an entitlement to shares of GCP Applied Technologies common stock.

Grace shareholders are urged to consult their financial and tax advisors regarding the particular consequences of the distribution in their situation, including, without limitation, the specific implications of selling GCP Applied Technologies shares and the applicability and effect of any U.S. federal, state, local, and foreign tax laws. Grace shareholders who hold common stock on the record date and decide to sell any of their Grace common stock before the distribution date should consult with their stockbroker, bank, or other nominee to understand whether the shares of Grace common stock will be sold with or without the entitlement to GCP Applied Technologies common stock pursuant to the distribution.

No action is required by Grace shareholders in order to receive GCP Applied Technologies shares in the distribution. Grace expects to mail the information statement regarding the separation to all Grace shareholders entitled to receive GCP Applied Technologies shares in the distribution. The information statement is an exhibit to the Registration Statement on Form 10 filed by GCP Applied Technologies with the SEC, and describes GCP Applied Technologies and its business, including details regarding the separation and distribution and certain risks of owning GCP Applied Technologies shares.

For more information, please consult the full Registration Statement on Form 10 filed by GCP with the SEC at http://www.sec.gov and visit Grace’s Investor Relations site.

About Grace

Grace is a leading global supplier of catalysts; engineered and packaging materials; and specialty construction chemicals and building materials. The company’s three industry-leading business segments—Grace Catalysts Technologies, Grace Materials Technologies, and Grace Construction Products—provide innovative products, technologies, and services that enhance the products and processes of our customer partners in over 155 countries around the world. Grace employs approximately 6,500 people in over 40 countries and had 2014 net sales of approximately $3.2 billion. More information about Grace is available at www.grace.com.

This announcement contains forward-looking statements, that is, information related to future, not past, events. Such statements generally include the words “ believes, ” “ plans, ” “ intends, ” “ targets, ” “ will, ” “ expects, ” “ suggests, ” “ anticipates, ” “ outlook, ” “ continues, ” or similar expressions. Forward-looking statements include, without limitation, expected financial positions; results of operations; cash flows; financing plans; business strategy; operating plans; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost reduction initiatives, plans and objectives; and markets for securities. For these statements, Grace claims the protection of the safe harbor for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act. Like other businesses, Grace is subject to risks and uncertainties that could cause its actual results to differ materially from its projections or that could cause other forward-looking statements to prove incorrect. Factors that could cause actual results to materially differ from those contained in the forward-looking statements include, without limitation: risks related to foreign operations, especially in emerging regions; the cost and availability of raw materials and energy; the effectiveness of its research and development and growth investments; acquisitions and divestitures of assets and gains and losses from dispositions; developments affecting Grace ’ s outstanding indebtedness; developments affecting Grace's funded and unfunded pension obligations; its legal and environmental proceedings; uncertainties that may delay or negatively impact the separation transaction or cause the separation transaction to not occur at all; uncertainties related to the company ’ s ability to realize the anticipated benefits of the spin-off; the inability to establish or maintain certain business relationships and relationships with customers and suppliers or the inability to retain key personnel during the period leading up to and following the separation transaction; costs of compliance with environmental regulation; and those additional factors set forth in Grace's most recent Annual Report on Form 10-K, quarterly report on Form 10-Q and current reports on Form 8-K, which have been filed with the Securities and Exchange Commission and are readily available on the Internet at www.sec.gov. Reported results should not be considered as an indication of future performance. Readers are cautioned not to place undue reliance on Grace's projections and forward-looking statements, which speak only as the date thereof. Grace undertakes no obligation to publicly release any revision to the projections and forward-looking statements contained in this announcement, or to update them to reflect events or circumstances occurring after the date of this announcement.

Media Relations Rich Badmington T +1 410.531.4370 rich.badmington@grace.com Investor Relations Tania Almond T +1 410.531.4590 tania.almond@grace.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Data Center Transformers on the Brink of a Boom

Updated Category News Views 272

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 50

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
Essity's SEK 850m Bet: Expanding Lilla Edet Facility

Updated Category News Views 99

Essity Doubling Down on Hygiene Hygiene is something you can't compromise on, and Essity gets that. They're shelling out a cool SEK 850 million into their production facility at Lilla Edet in Sweden—no small change, even in the grand scheme of corporate investment. Why the Massive Investment? It's not just about throwing money around; this move is strategic. Essity’s...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 183

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 24

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
Eve Air Mobility's Vector System Proves Its Worth

Updated Category News Views 84

Eve Air Mobility's Vector system just pulled off something impressive at the Interlagos Circuit, showing it's not just a buzzword in the urban air mobility sphere. Picture this—over 100 helicopter flights in a day, all managed smoothly during one of the biggest motorsport events. That's the kind of action that gets investors to sit up and take notice of NYSE:EVEX....

Continue Reading
NueSynergy Secures Top Spot in HSA Provider Rankings

Updated Category News Views 107

NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...

Continue Reading
SciGround Launches: A Game-Changer in Research Verification

Updated Category News Views 148

Unshackling Research Verification from the Model Folks, here's the big one—Licklider, Inc. from Tokyo lobbed a curveball with their new player in town: SciGround. This platform takes the reins on mathematically verifying AI-driven research, which is something you'll want to keep an eye on if you're at all interested in AI or research replication. Why SciGround Gets My...

Continue Reading
JardogsHealth Taps Industry Titans for Growth Council

Updated Category News Views 99

JardogsHealth: A New Chapter with Strategic Insights You've got to admire when a company rounds up a top-tier brain trust. Such is the case with JardogsHealth, the healthcare AI outfit nestled in Hillsboro, Illinois, as they align their future alongside heavyweights who’ve maneuvered through multiple industries and come out thriving. Their brand-new council includes...

Continue Reading
Dahua's Pro Challenge 2026: Bridging Expertise Globally

Updated Category News Views 90

Celebrating Global Installer Expertise Dahua Technology took to the stage in Hangzhou for the Pro Challenge 2026, a shindig pulling installer partners from every corner of the globe. This wasn't just a tech jamboree; it was a tip of the hat to those on the ground who make Dahua's AIoT solutions tick. You know the drill: hands-on demos, tech showcases, and a whole lot of...

Continue Reading

Top 5 Most Recently Viewed Articles

AI’s Dual Nature: Growth Potential or Path to Collapse?

Updated Category News Views 242

The Dichotomy of AI: Catalyst for Growth or Collapse? Yes, AI is a catalyst, though what it catalyzes remains uncertain. The prevailing narrative suggests that our foremost challenge is the need for affordable energy to support the burgeoning data centers of AI technology. Fortunately, solutions are emerging, including the construction of modular nuclear power plants and...

Continue Reading
Ponche Kuba Refreshes Its Look While Keeping Original Flavor

Updated Category News Views 280

Exciting New Look for Ponche Kuba Today marks an exciting chapter in the world of liqueurs as Ponche Kuba unveils its new packaging design, an evolution of its iconic Caribbean rum cream liqueur. Since its inception in 1942 by Don Jaime A. J. Sprock, Ponche Kuba has maintained a loyal following due to its unique flavor and quality. Although the aesthetic has transformed,...

Continue Reading
Unlocking Crypto Success: Double Bonuses and 100x Leverage

Updated Category News Views 129

BexBack Introduces Exciting Crypto Trading Offers BexBack is revolutionizing the cryptocurrency trading landscape with dynamic offers designed for traders looking to capitalize on recent market volatility. Following significant developments in the industry, BexBack has stepped up to provide traders with exceptional options, making it easier than ever to start trading....

Continue Reading
Innovative Partnership Between eMolecules and Optic for Drug Discovery

Updated Category News Views 75

Transforming Drug Discovery with AI Collaboration In an exciting development for the pharmaceutical industry, eMolecules, a leading chemical sourcing company, has joined forces with Optic, a digital biology firm. This collaboration aims to revolutionize the drug discovery process by leveraging the power of artificial intelligence. Together, these companies are creating a...

Continue Reading
Vivani Medical Advances Canine Health with Expanded Collaboration

Updated Category News Views 214

Collaborative Efforts to Enhance Canine Metabolic Health Vivani Medical, Inc. and Okava Pharmaceuticals, Inc. have announced an exciting expansion of their partnership, aiming to enhance the metabolic health and longevity of dogs. With a mutual vision for veterinary medicine, the collaboration focuses on the development of OKV-119, a long-acting GLP-1 therapy designated...

Continue Reading